Published in J Pharmacol Exp Ther on July 27, 2004
Retracted Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol (2010) 1.72
Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability. J Inherit Metab Dis (2013) 0.89
The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells. J Cereb Blood Flow Metab (2014) 0.86
The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells. Br J Pharmacol (2012) 0.85
A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs. Biomed Res Int (2015) 0.84
Preparation, characterization, and in vitro intestinal permeability evaluation of thalidomide-hydroxypropyl-β-cyclodextrin complexes. AAPS PharmSciTech (2011) 0.81
Interactions between cyclodextrins and cellular components: Towards greener medical applications? Beilstein J Org Chem (2016) 0.77
Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs. Int J Nanomedicine (2016) 0.75
MHC studies in nonmodel vertebrates: what have we learned about natural selection in 15 years? J Evol Biol (2003) 3.26
A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol (1997) 1.64
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci U S A (2001) 1.49
An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem (1990) 1.43
In vitro models for the blood-brain barrier. Toxicol In Vitro (2005) 1.41
Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. J Neurochem (1992) 1.32
Genome sequence of Edwardsiella ictaluri 93-146, a strain associated with a natural channel catfish outbreak of enteric septicemia of catfish. J Bacteriol (2012) 1.16
Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem (1999) 1.15
Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res (1995) 1.13
Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers. Pharm Res (2000) 1.09
Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. J Cell Biol (1994) 1.08
3D reconstruction method from biplanar radiography using non-stereocorresponding points and elastic deformable meshes. Med Biol Eng Comput (2000) 1.04
Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier. J Pharmacol Exp Ther (2004) 1.03
High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene. J Immunol (2000) 1.02
Cell-specific expression of high levels of human S100 beta in transgenic mouse brain is dependent on gene dosage. J Neurosci (1992) 1.00
Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. J Pharmacol Exp Ther (1999) 0.98
Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol (1996) 0.97
Catabolic pathway of oligosaccharide-diphospho-dolichol. Study of the fate of the oligosaccharidic moiety in mouse splenocytes. Eur J Biochem (1987) 0.96
Functional analysis of the Numb phosphotyrosine-binding domain using site-directed mutagenesis. J Biol Chem (1998) 0.96
Low-density lipoprotein receptor on endothelium of brain capillaries. J Neurochem (1989) 0.95
Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture. J Neurochem (1989) 0.95
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens (1998) 0.95
Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience (2005) 0.94
Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharm Res (1999) 0.94
Hypoxia dramatically increases the nonspecific transport of blood-borne proteins to the brain. J Neurochem (1997) 0.93
Solubilisation of chlorinated solvents by cyclodextrin derivatives: a study by static headspace gas chromatography and molecular modelling. J Hazard Mater (2006) 0.92
Reduction in S100 protein beta subunit mRNA in C6 rat glioma cells following treatment with anti-microtubular drugs. J Biol Chem (1987) 0.91
Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int J Pharm (2009) 0.91
Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles. Infect Immun (2002) 0.90
Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J Neurochem (1995) 0.90
Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide. J Neurochem (1998) 0.89
Conditionally immortalized oligodendrocyte cell lines migrate to different brain regions and elaborate 'myelin-like' membranes after transplantation into neonatal shiverer mouse brains. Dev Neurosci (1995) 0.88
Influence of the embryonic preplate on the organization of the cerebral cortex: a targeted ablation model. J Neurosci (2002) 0.88
Cyclodextrins as supramolecular hosts for organometallic complexes. Chem Rev (2006) 0.88
Characterization and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles. Biochim Biophys Acta (1997) 0.87
Characterization of angiogenin receptors on bovine brain capillary endothelial cells. Biochem Biophys Res Commun (1991) 0.87
The neuroprotective activity of 8-alkylamino-1,4-benzoxazine antioxidants. Eur J Pharmacol (2001) 0.86
Blood-brain interfaces: relevance to cerebral drug metabolism. Toxicol Lett (1995) 0.86
Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations. Antimicrob Agents Chemother (2002) 0.86
Postnatal localization and morphogenesis of cells expressing the dopaminergic D2 receptor gene in rat brain: expression in non-neuronal cells. J Comp Neurol (1998) 0.86
Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J Neurochem (1999) 0.86
Effect of high-intensity interval training and detraining on extra VO2 and on the VO2 slow component. Eur J Appl Physiol (2007) 0.84
Schistosoma mansoni activates host microvascular endothelial cells to acquire an anti-inflammatory phenotype. Infect Immun (1999) 0.84
Endothelin-1 as a mediator of endothelial cell-pericyte interactions in bovine brain capillaries. J Cereb Blood Flow Metab (1997) 0.84
Viral neuraminidase and cellular ectosialyltransferase in human lymphoblastoid cells infected with influenza virus. Biochimie (1984) 0.83
Intralumenal pool and transport of CMP-N-acetylneuraminic acid, GDP-fucose and UDP-galactose. Study with plasma-membrane-permeabilized mouse thymocytes. Biochem J (1984) 0.81
Membrane transport of sugar donors to the glycosylation sites. Biochimie (1987) 0.81
Neuroprotective properties of tianeptine: interactions with cytokines. Neuropharmacology (2003) 0.80
Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier. J Control Release (1998) 0.80
Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro. J Lipid Res (1998) 0.79
Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier. Pharm Res (1998) 0.79
Glycosylation of proteins from sugar nucleotides by whole cells. Effect of ammonium chloride treatment on mouse thymocytes. Biochem J (1983) 0.79
A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration. Eur J Cancer (2001) 0.79
Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3',5'-monophosphate. Exp Physiol (1995) 0.79
Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier. J Neurochem (1999) 0.79
APH-1, a POU homeobox gene expressed in the salt gland of the crustacean Artemia franciscana. Mech Dev (1999) 0.79
The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: results from the European Project ACuteTox. Toxicol In Vitro (2012) 0.79
Histamine induces a selective albumin permeation through the blood-brain barrier in vitro. Inflamm Res (1995) 0.78
Fatty acid composition of brain capillary endothelial cells: effect of the coculture with astrocytes. J Lipid Res (1995) 0.78
Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells. Int J Pharm (2013) 0.78
Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway. J Neurochem (1999) 0.78
A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens. Vaccine (1996) 0.78
Receptor-mediated transcytosis of cyclophilin B through the blood-brain barrier. J Neurochem (1999) 0.78
Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers. J Neuroimmunol (1997) 0.78
Dilatation of Golgi vesicles by monensin leads to enhanced accumulation of sugar nucleotides. Biosci Rep (1986) 0.78
Accumulation of UDP-GlcNAc into intracellular vesicles and occurrence of a carrier-mediated transport. Study with plasma-membrane-permeabilized mouse thymocytes. Eur J Biochem (1985) 0.78
Blood-brain barrier pericytes are the main source of gamma-glutamyltranspeptidase activity in brain capillaries. J Neurochem (1992) 0.77
Drug transfer across the blood-brain barrier: comparison of in vitro and in vivo models. Adv Exp Med Biol (1993) 0.77
Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors. Vaccine (1994) 0.77
Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline? Pharm Res (2004) 0.77
Interactions of high-density lipoprotein 3 with brain capillary endothelial cells. Biochim Biophys Acta (1989) 0.76
IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy. Cytotherapy (2002) 0.76
Effect of prior heavy exercise on muscle deoxygenation kinetics at the onset of subsequent heavy exercise. Eur J Appl Physiol (2007) 0.76
Accelerated Caco-2 cell permeability model for drug discovery. J Pharmacol Toxicol Methods (2013) 0.76
In vitro blood-brain barrier model adapted to repeated-dose toxicological screening. Toxicol In Vitro (2013) 0.75
Using cost-volume-profit methods to purchase open MRI equipment. Radiol Manage (1996) 0.75
[Lateral gaze paralysis with automatico-voluntary dissociation. A case]. Rev Otoneuroophtalmol (1985) 0.75
Thermoresponsive self-assembled cyclodextrin-end-decorated PNIPAM for aqueous catalysis. Chem Commun (Camb) (2015) 0.75
Fluosol 43 intravascular persistence in mice measured by 19F nmr. J Pharm Pharmacol (1984) 0.75
Cyclodextrin-based PNN supramolecular assemblies: a new class of pincer-type ligands for aqueous organometallic catalysis. Dalton Trans (2015) 0.75